Hedge Fund - Baker Bros. Advisors
Salix Pharmaceuticals Ltd (SLXP) CONV BONDS
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2015 - Q2 (2015-06-30) | $0 | 0% | 0 | $ |
| 2 | 2015 - Q1 (2015-03-31) | $801,152,000 | 6.66% | 216,077,000 | $ |
| 3 | 2014 - Q4 (2014-12-31) | $542,741,000 | 5.53% | 219,440,000 | $ |
| 4 | 2014 - Q3 (2014-09-30) | $737,019,000 | 9.28% | 219,440,000 | $ |
| 5 | 2014 - Q2 (2014-06-30) | $585,836,000 | 7.17% | 219,440,000 | $ |
| 6 | 2014 - Q1 (2014-03-31) | $491,957,000 | 6.25% | 219,440,000 | $ |
| 7 | 2013 - Q4 (2013-12-31) | $431,748,000 | 6.08% | 219,440,000 | $ |
| 8 | 2013 - Q3 (2013-09-30) | $335,332,000 | 4.76% | 219,440,000 | $ |
| 9 | 2013 - Q2 (2013-06-30) | $334,029,000 | 6.6% | 219,440,000 | $ |
| 10 | 2013 - Q1 (2013-03-31) | $220,383,000 | 4.39% | 170,922,000 | $ |
| 11 | 2012 - Q4 (2012-12-31) | $126,398,000 | 3.3% | 110,572,000 | $ |
| 12 | 2012 - Q3 (2012-09-30) | $129,439,000 | 2.85% | 110,572,000 | $ |
| 13 | 2012 - Q1 (2012-03-31) | $147,890,000 | 3.95% | 110,572,000 | $ |
| 14 | 2011 - Q4 (2011-12-31) | $129,361,000 | 4.27% | 100,572,000 | $ |
| 15 | 2011 - Q3 (2011-09-30) | $100,724,000 | 4.28% | 101,741,000 | $ |
| 16 | 2011 - Q2 (2011-06-30) | $149,960,000 | 5.74% | 130,400,000 | $ |
| 17 | 2011 - Q1 (2011-03-31) | $140,343,000 | 5.84% | 130,400,000 | $ |
| 18 | 2010 - Q4 (2010-12-31) | $166,260,000 | 7.24% | 130,400,000 | $ |
The displayed share prices are average quarterly stock market prices.